Insider · CIK 0001922605

Chung Wendy

Reports to the SEC for 2 companies · EAST BERLIN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001922605

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	RLYBRallybio CorpM Exercise/Conversion	Director	MExercise/Conversion	+3,562 sh	$2.38	+$8,477.56	3,562
2026-09-16	RLYBRallybio Corp · Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,562 sh	—	—	0
2026-06-05	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,006 sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,006 sh	—	—	9,006
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−39.1K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.1K sh	—	—	39,062
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,510
2025-06-04	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2025-05-13	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,500
2024-06-12	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-05-15	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2023-06-14	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.1K sh	—	—	39,062
2023-05-17	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,353
2023-01-03	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+9,482 sh	—	—	9,482
2022-10-19	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,006 sh	—	—	9,006
2022-08-01	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+26.9K sh	—	—	26,880

Recent filings

Accepted (ET)
Sep 184
Chung Wendy0001193125-26-395755
SEC(opens sec.gov)
Jun 84
Chung Wendy0001628280-26-041560
SEC(opens sec.gov)
Aug 54
Chung Wendy0001894562-25-000045
SEC(opens sec.gov)
Jun 54
Chung Wendy0001628280-25-029769
SEC(opens sec.gov)
May 154
Chung Wendy0001739410-25-000086
SEC(opens sec.gov)
Jun 144
Chung Wendy0001894562-24-000036
SEC(opens sec.gov)
May 174
Chung Wendy0001739410-24-000087
SEC(opens sec.gov)
Jun 164
Chung Wendy0001894562-23-000023
SEC(opens sec.gov)
May 194
Chung Wendy0000899243-23-013393
SEC(opens sec.gov)
Jan 54
Chung Wendy0000899243-23-001046
SEC(opens sec.gov)
Oct 214
Chung Wendy0001628280-22-026824
SEC(opens sec.gov)
Aug 34
Chung Wendy0000899243-22-027631
SEC(opens sec.gov)

Companies

Address

C/O RALLYBIO CORPORATION PO BOX 325

EAST BERLIN, CT, 06023